Hypoglycaemia: the limiting factor in the glycaemic management of type I and type II diabetes.
The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Abstract
Hypoglycaemia is the limiting factor in the glycaemic management of diabetes. Iatrogenic hypoglycaemia is typically the result of the interplay of insulin excess and compromised glucose counterregulation in Type I (insulin-dependent) diabetes mellitus. Insulin concentrations do not decrease and glucagon and epinephrine concentrations do not increase normally as glucose concentrations decrease. The concept of hypoglycaemia-associated autonomic failure (HAAF) in Type I diabetes posits that recent antecedent iatrogenic hypoglycaemia causes both defective glucose counterregulation (by reducing the epinephrine response in the setting of an absent glucagon response) and hypoglycaemia unawareness (by reducing the autonomic and the resulting neurogenic symptom responses). Perhaps the most compelling support for HAAF is the finding that as little as 2 to 3 weeks of scrupulous avoidance of hypoglycaemia reverses hypoglycaemia unawareness and improves the reduced epinephrine component of defective glucose counterregulation in most affected patients. The mediator and mechanism of HAAF are not known but are under active investigation. The glucagon response to hypoglycaemia is also reduced in patients approaching the insulin deficient end of the spectrum of Type II (non-insulin-dependent) diabetes mellitus, and glycaemic thresholds for autonomic (including epinephrine) and symptomatic responses to hypoglycaemia are shifted to lower plasma glucose concentrations after hypoglycaemia in Type II diabetes. Thus, patients with advanced Type II diabetes are also at risk for HAAF. While it is possible to minimise the risk of hypoglycaemia by reducing risks -- including a 2 to 3 week period of scrupulous avoidance of hypoglycaemia in patients with hypoglycaemia unawareness -- methods that provide glucose-regulated insulin replacement or secretion are needed to eliminate hypoglycaemia and maintain euglycaemia over a lifetime of diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Because of steady improvements in the glycemic management of diabetes, it is possible both to improve glycemic control and to minimize the risk of hypoglycemia in many patients (12, 16, 84 -86).”
From Evaluation and Management of Adult Hypoglycemic Disorders: An Endocrine Society Clinical Practice Guideline (2009) · cites this paper as [84]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Hypoglycemia in diabetes is fundamentally the result of treatments that raise insulin levels and thus lower plasma glucose concentrations (12,16,84,85).”
From Evaluation and Management of Adult Hypoglycemic Disorders: An Endocrine Society Clinical Practice Guideline (2009) · cites this paper as [84]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Those treatments include insulin or insulin secretagogues such as a sulfonylurea or a nonsulfonylurea insulin secretagogue (e.g.nateglinide or repaglinide).”
From Evaluation and Management of Adult Hypoglycemic Disorders: An Endocrine Society Clinical Practice Guideline (2009) · cites this paper as [84]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In type 1 diabetes, deficiency of the secretory response of glucagon to hypoglycemia is an early acquired abnormality of counterregulation.The catecholamine response compensates for several years but declines with time (1).”
From Hypoglycemia in Type 2 Diabetes (2005) · cites this paper as [1]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Treatment-induced hypoglycemia is the limiting factor in the glycemic management of diabetes (12,16,84).”
From Evaluation and Management of Adult Hypoglycemic Disorders: An Endocrine Society Clinical Practice Guideline (2009) · cites this paper as [84]
15 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Plum, F. (1960) · Archives of Neurology · doi:10.1001/archneur.1960.03840090124020 · Cited by 10,364
Stratton, I. M. (2000) · BMJ · doi:10.1136/bmj.321.7258.405 · Cited by 9,059 · cited 2×
“Enough insulin, or any effective drug, to lower plasma glucose concentrations to or below the normal range would eliminate the symptoms of hyperglycaemia, prevent the acute hyperglycaemic complications (ketoacidosis, hyperosmolar syndrome), almost assuredly prevent the long-term microvascular complications [1, 2] and…”
BackgroundKhaw, K.-T. (2001) · BMJ · doi:10.1136/bmj.322.7277.15 · Cited by 1,017
Gold, A. E., Macleod, K. M., & Frier, B. M. (1994) · Diabetes Care · doi:10.2337/diacare.17.7.697 · Cited by 810
Gerich, J. E., Langlois, M., Noacco, C., Karam, J. H., & Forsham, P. H. (1973) · Science · doi:10.1126/science.182.4108.171 · Cited by 688 · cited 1×
“Finally, we and others have begun to study the mechanisms of the normal glucagon response to hypoglycaemia with the aim of gaining insight into the mechanism of the absence of the glucagon response in Type I diabetes [22], a critical component of defective glucose counterregulation and HAAF.”
BackgroundMitrakou, A., Ryan, C., Veneman, T., Mokan, M., Jenssen, T., Kiss, I., Durrant, J., Cryer, P., & Gerich, J. (1991) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1991.260.1.e67 · Cited by 558 · cited 2×
“0 mmol/l (54 mg/dl) respectively) are reproducible in healthy subjects [13, 14, 15], they shift to higher plasma glucose concentrations in poorly controlled diabetes [16, 17] and to lower plasma glucose concentrations following episodes of hypoglycaemia [18, 19, 20, 21].”
BackgroundSelf-citationHeller, S. R., & Cryer, P. E. (1991) · Diabetes · doi:10.2337/diab.40.2.223 · Cited by 531
Self-citation&NA; (1994) · Survey of Anesthesiology · doi:10.1097/00132586-199406000-00052 · Cited by 487
Dagogo-Jack, S. E., Craft, S., & Cryer, P. E. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116302 · Cited by 471
Self-citation
Cited by
Items 601–700 of 793
Inzucchi, S. E., Bergenstal, R. M., Buse, J. B., Diamant, M., Ferrannini, E., Nauck, M. A., Peters, A. L., Τσάπας, Α., Wender, R. C., & Matthews, D. R. (2012) · Cited by 3
Biester, T., Remus, K., Holder, M., Aschemeier, B., Kieninger‐Baum, D., Wadien, T., Kordonouri, O., Danne, T., & Thomas, A. (2017) · Diabetologie und Stoffwechsel · doi:10.1055/s-0043-114867 · Cited by 3
Herranz-Antolín, S., de Frutos, V. Á., & Torralba, M. (2018) · Endocrinología Diabetes y Nutrición · doi:10.1016/j.endinu.2017.11.006 · Cited by 3
Structure and properties of insulin
Gupta, A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820234-0.00004-4 · Cited by 5
Physiological and Pathophysiological Control of Glucagon Secretion by Pancreatic α-Cells
Gilon, P., Cheng, R., Lai, B. K., Chae, H., & Gómez-Ruiz, A. (2014) · Springer eBooks · doi:10.1007/978-94-007-6686-0_37 · Cited by 4
Ileal interposition surgery for treatment of type 2 diabetes mellitus-pros and cons
Payab, M., & Sh, H.-R. (2015) · Journal of Diabetes & Metabolic Disorders · doi:10.1186/s40200-015-0202-x · Cited by 4
“In advanced T2DM, iatrogenic hypoglycemia can be a limiting factor for these procedures [28].”
BackgroundAn investigation of type 2 diabetes self-management in Taiwan.
Wu, H.-L. (2009) · Nottingham ePrints (University of Nottingham) · Cited by 4
Thesis submitted in partial fulfilment of the requirements for the degree of
Aslani, S. (2018) · Cited by 3
Standards of Medical Care in Diabetes
American Diabetes Association (2005) · Diabetes Care · doi:10.2337/diacare.28.suppl_1.s4 · Cited by 2
Ahmed, A. E., Tan, Z., El-Radi, W. A., & Rajamani, K. K. (2025) · Cureus · doi:10.7759/cureus.92175 · Cited by 5
A 10‐second sprint does not blunt hormonal counter‐regulation to subsequent hypoglycaemia
Paramalingam, N., Fournier, P. A., Davey, R. J., Roby, H. C., Smith, G. J., Shetty, V. B., Guelfi, K. J., Davis, E. A., & Jones, T. W. (2017) · Diabetic Medicine · doi:10.1111/dme.13396 · Cited by 2
Brown, J. B., Reichert, S. M., Valliere, Y., McLachlan, C., Webster-Bogaert, S., Ratzki‐Leewing, A. A., Ryan, B. L., & Harris, S. B. (2021) · Diabetes Spectrum · doi:10.2337/ds20-0061 · Cited by 2
“The consequences of hypoglycemia are well described and can include both physical (5,6) and psychological (7–11) morbidity, as well as social issues such as employment limitations, financial concerns, and challenging social interactions (12).”
BackgroundAn update on dental caries in children with type 1 diabetes mellitus
He, I., Smart, G., Poirier, B., Sethi, S., & Jensen, E. D. (2022) · Pediatric Dental Journal · doi:10.1016/j.pdj.2022.05.001 · Cited by 4
Suri, P., & Aurora, T. K. (2017) · Cambridge University Press eBooks · doi:10.1017/9781139136365.044 · Cited by 2
Características clínico-epidemiológicas de las complicaciones agudas de la diabetes mellitus
Sansores, C. J. C., Aké, O. C., Herrera, S. P., & Losa, M. D. R. G. (2005) · Medicina Interna de México · Cited by 2
Azriel, S., Casal, F., Dalama, B., Varillas, F., Bajo, Á. V., Soto, A., & Barberá, G. (2014) · Endocrinología y Nutrición · doi:10.1016/j.endonu.2014.06.004 · Cited by 2
Variability of Insulin Action and Clinical Effects
Asamoah, E. (2007) · The Endocrinologist · doi:10.1097/ten.0b013e318156355f · Cited by 2
Self-Monitoring of Blood Glucose in Glucagon-Like Peptide-1–Based Treatment Approaches
Schnell, O., & Felton, A.-M. (2013) · Diabetes Spectrum · doi:10.2337/diaspect.26.2.107 · Cited by 2
Qaisar, S., Khan, S., & Imtiaz, S. (2012) · Lecture notes in computer science · doi:10.1007/978-3-642-31137-6_26 · Cited by 4
“Though closed loop treatments in clinical environments have greatly enhanced diabetes control and care over the last few decades [5], hypoglycemia remains a major unsolved problem to achieve strict glycemic control [5, 7].”
BackgroundA 1-year, randomized, treat-to-target trial (BEGIN Once Long)
Zinman, B., Philis‐Tsimikas, A., Cariou, B., Handelsman, Y., Rodbard, H. W., Johansen, T., Endahl, L. A., & Mathieu, C. (2012) · Cited by 2
Insulin Therapy in Type 2 Diabetes
Moghissi, E. S. (2013) · US Endocrinology · doi:10.17925/use.2013.09.01.6 · Cited by 2
Hypoglycemic Morbidity and Mortality in Diabetes
Son, J. W. (2016) · Journal of Korean Diabetes · doi:10.4093/jkd.2016.17.1.17 · Cited by 2
“제1형 당뇨병 환자의 경우 6~10%가 저혈당으 로 인해 사망한다는 보고가 있으며[2], 유병기간이 긴 제2 형 당뇨병 환자들에서 저혈당으로 인한 높은 이환율이 보고 되고 있다[3,4].”
Impact of the TCF7L2 genotype on risk of hypoglycaemia and glucagon secretion during hypoglycaemia
Kristensen, P. L., Pedersen‐Bjergaard, U., Due-Andersen, R., Høi-Hansen, T., Bie-Olsen, L. G., Lyssenko, V., Groop, L., Holst, J. J., Vaag, A. A., & Thorsteinsson, B. (2016) · Endocrine Connections · doi:10.1530/ec-16-0050 · Cited by 2
Glycemic Variability in Type 1 Diabetes Mellitus Saudis Using Ambulatory Glucose Profile
Alzahrani, B. S., ALZAHRANI, S. H., Almalki, M., Elabd, S. S., Khan, S. A., Buhary, B. M., Aljuhani, N., & Jammah, A. A. (2021) · Clinical Medicine Insights Endocrinology and Diabetes · doi:10.1177/11795514211013789 · Cited by 2
Uduku, C. N., Pendolino, V., Godsland, I. F., Oliver, N. S., Reddy, M., & Fothergill, R. T. (2021) · Diabetic Medicine · doi:10.1111/dme.14654 · Cited by 3
(SFD), U. P. D. P. P. P. L. S. F. D. D. (2012) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(12)70660-0 · Cited by 2
Classification and prediction of hypoglycemia in diabetic patients using machine learning techniques
Shastri, S., & Sandhya, P. (2022) · International Journal of Health Sciences · doi:10.53730/ijhs.v6ns4.10741 · Cited by 2
73rd Congress of the Italian Society of Pediatrics: Naples, Italy. 30th May - 1st June 2017
2011, T. I. O. F. C. A. A. W. E. B. L. N. 1. O. 1. J., age, W. A. V. T. E. T. F. I. A. P. O. T. R. A. I. O. P. O. M., conventions, I. A. W. T. P. O. I., Child, W. P. R. T. T. C. O. T. R. O. T., 1989, S. I. N. Y. O. 2. N., & 1991., A. I. I. I. T. L. N. 1. O. 2. M. (2017) · The Italian Journal of Pediatrics/Italian journal of pediatrics · doi:10.1186/s13052-017-0427-z · Cited by 4
Hyperglycaemia in people with diabetes and chronic kidney disease
Brøsen, J. M. B., Bomholt, T., Borg, R., Persson, F., & Pedersen‐Bjergaard, U. (2024) · Ugeskrift for Læger · doi:10.61409/v01240051 · Cited by 2
Starting insulin therapy in type 2 diabetes: lesson 1.
McCall, A. L. (2005) · PubMed · Cited by 2
Inulin might exceed incretin based drugs in the treatment of type 2 diabetes mellitus
Girgiss, M. W., Nicola, W. G., El-Arab, A. M. E., Habib, D. F., Ahmed, N. M., & Youness, E. R. (2019) · Biomedical & Pharmacology Journal · doi:10.13005/bpj/1732 · Cited by 3
Clinical – Metabolic, Endocrine
Mace, S. E. (2017) · Cambridge University Press eBooks · doi:10.1017/9781139136365.043 · Cited by 2
Hipoglucemia en la diabetes, fisiopatología, clínica y tratamiento
Cabezas-Cerrato, J. (2004) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/s0211-3449(04)70155-1 · Cited by 2
Howorka, K., Pumprla, J., Gabriel, M., THOMA, H., & Schabmann, A. (2003) · The International Journal of Artificial Organs · doi:10.1177/039139880302600805 · Cited by 2
“Even a slight and symptomfree hypoglycemia further increases hypoglycemia unawareness so that an early detection of low blood glucose values will have a major impact for restoration of hypoglycemia awareness (21, 22).”
BackgroundAutomated optimal glycaemic control using a physiology based pharmacokinetic, pharmacodynamic model
Schaller, S., Schuppert, A., & Mitsos, A. (2015) · RWTH Publications (RWTH Aachen) · Cited by 6
Self‐monitoring of Blood Glucose
Skyler, J. S. (2004) · Wiley eBooks · doi:10.1002/0470862092.d0805 · Cited by 2
The effectiveness of telephone consultation in the management of patients with diabetes mellitus
Joseph, P. (2013) · ChesterRep (University of Chester) · Cited by 3
Modellig of adrenaline counterregulatory action during hypoglycaemia in Type 1 Diabetes
Moscardo, V., Rossetti, P., Ampudia-Blasco, F. J., & Bondia, J. (2016) · 2016 IEEE Conference on Control Applications (CCA) · doi:10.1109/cca.2016.7587868 · Cited by 2
“intensive glucose control with multiple daily injections and continuous subcutaneous insulin infusion (CSII) pump therapy), although good glycaemic control is still a challenge due, among other things, to large intra-subject variability [1].”
BackgroundDIABETES MANAGEMENT AND CURRENT PROSPECTS FOR SELF-MONITORING OF BLOOD GLUCOSE
Валерьевна, Г. Е., & Petunina, N. A. (2017) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2017-3-17-21 · Cited by 3
Villa-Tamayo, M. F., Colmegna, P. H., & Breton, M. D. (2023) · Journal of Diabetes Science and Technology · doi:10.1177/19322968231212205 · Cited by 2
Estimation of HbA1c and Impact of Continuous Glucose Monitoring in Hypoglycemic States
Mishra, B. K., Raghav, A., Jeong, G., Jain, M. K., Shukla, P., & Sharma, S. (2024) · IntechOpen eBooks · doi:10.5772/intechopen.1005805 · Cited by 2
Hypoglycemia in the Emergency Department
Harding, A. D. (2012) · Journal of Emergency Nursing · doi:10.1016/j.jen.2012.01.008 · Cited by 1
A CMOS pancreatic islet of Langerhans for automatic glycemic regulation
Banks, D., Morris, C., Omeru, J. O., Wei, W., Georgiou, P., & Toumazou, C. (2011) · IEEE Biomedical Circuits and Systems Conference (BioCAS) · doi:10.1109/biocas.2011.6107777 · Cited by 1
“Despite the benefits of continuous insulin infusion, there is an increased risk of low blood glucose (hypoglycaemia) episodes [5] [6].”
BackgroundHipoglucemia en pacientes diab?ticos tipo 2
Gonzlez, J. P. M., Prez, E. P., Martín-Oterino, J.-Á., & Cengoitiabengoa, M. B. (2008) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/s0211-3449(08)73228-4 · Cited by 2
Kim, E. J., Jeong, M. H., Jeong, I. S., Oh, S. G., Kim, S. H., Ahn, Y. K., Kim, J. H., Kim, Y. J., Chae, S. C., Hong, T. J., et al. (2014) · Korean Journal of Medicine · doi:10.3904/kjm.2014.87.5.565 · Cited by 1
“그러나 혈당 조절 목표가 엄격해짐에 따라 저혈당의 빈도 또한 증가하고 있으며, 저혈당은 혈당 조절의 중요한 장애요 인으로 작용한다[10,11].”
Hyperglycemia Management in Non-critically Ill Hospitalized Patients
Arnold, L. M., Keller, D. L., & Tofade, T. S. (2009) · Journal of Pharmacy Practice · doi:10.1177/0897190008330198 · Cited by 1
Azriel, S., Casal, F., Dalama, B., Varillas, F., Bajo, Á. V., Soto, A., & Barberá, G. (2014) · Endocrinología y Nutrición (English Edition) · doi:10.1016/j.endoen.2014.11.004 · Cited by 1
Chandalia, H. B., & Thadani, P. (2016) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-016-0467-8 · Cited by 1
“The increased susceptibility toward hypoglycemia in patients with type 1 diabetes is further exacerbated by impaired glucagon release in response to hypoglycemia [44].”
BackgroundKolassa, R., Thomas, A., & Siegmund, T. (2014) · Diabetes aktuell · doi:10.1055/s-0034-1372224
Karthikeyan, V. (2014) · Cited by 1
CARDIOVASCULAR SAFETY OF GLIPTINS. FOCUS ON ALOGLIPTIN
Petunina, N. A., Валерьевна, Г. Е., & Potapova, S. A. (2017) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2017-3-32-37 · Cited by 1
PANCREATIC ALPHA CELL DYSFUNCTION IN DIABETES MELLITUS AND ITS MANAGEMENT STRATEGIES
Pradhan, B., & Majhi, C. (2017) · Journal of Evidence Based Medicine and Healthcare · doi:10.18410/jebmh/2017/551 · Cited by 2
HRAMIAK, I. M., Punthakee, Z., Groleau, M., Javadi, P., Bigot, G., & Woo, V. C. (2017) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.1000782
“Furthermore, the fear of hypoglycemia has been shown to be a major barrier to starting insulin therapy in patients with diabetes mellitus [25-27].”
BackgroundShould all patients on insulin be using continuous glucose monitoring?
Distiller, L. A. (2018) · Journal of Endocrinology Metabolism and Diabetes of South Africa · doi:10.1080/16089677.2018.1515164 · Cited by 1
“Hypoglycaemia With attempts at tighter glycaemic control, hypoglycaemia has become a significant problem, even in those with so-called ‘preserved hypoglycaemia awareness’(34) and is considered one of the main limiting factors in achieving good glycaemic control.(35) The use of CGM allows not only for the detection of…”
BackgroundHypoglycemia and Hypoglycemic Syndromes
Davis, S. N. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5583-9.00047-2 · Cited by 2
Patient reported experience of blood glucose management when undergoing hyperbaric oxygen treatment
Baines, C. R., O’Rourke, G. A., Miller, C., Ford, K., & McGuiness, W. (2018) · Collegian Journal of the Royal College of Nursing Australia · doi:10.1016/j.colegn.2018.11.004 · Cited by 1
Insulin therapy in patients with type 2 diabetes mellitus
Odeniyi, I. A., Olopade, O. B., & Fasanmade, O. A. (2019) · Journal of Clinical Sciences · doi:10.4103/jcls.jcls_5_18 · Cited by 3
“[5] Iatrogenic hypoglycemia hampers tight glycemic control and is considered the limiting factor in diabetes management.[39] In Type 2 diabetes, the frequency of hypoglycemia is generally lower than that in Type 1 diabetes.”
BackgroundPedersen-Bjergaard, L. (2008) · Cited by 1
Wohlschläger‐Krenn, E., Luger, A., & Gessl, A. (2010) · Wiener klinische Wochenschrift Education · doi:10.1007/s11812-010-0076-2 · Cited by 1
Scherbaum, W. A., & Scherbaum, C. R. (2014) · Der Diabetologe · doi:10.1007/s11428-013-1189-x · Cited by 1
Zhang, L., Guo, K., Xu, Y., Bai, J., Ma, Y., Fu, L., Liu, J., Hu, K., Li, X., Jiang, H., et al. (2022) · PubMed Central · doi:10.11817/j.issn.1672-7347.2022.210524 · Cited by 1
Psychometric Properties of Turkish Version of Hypoglycemia Attitudes and Behavior Scale
İnkaya, B. V., & Düzalan, Ö. B. (2022) · Turkish Journal of Family Medicine & Primary Care · doi:10.21763/tjfmpc.992579 · Cited by 1
Unveiling the Significance of the ‘Bathtub’ Shape in Blood Glucose Curve Analysis
Fetian, I. R. (2024) · IntechOpen eBooks · doi:10.5772/intechopen.1003746 · Cited by 1
Esercizio fisico nel diabete mellito di tipo 1
Haxhi, J., & Bellini, A. (2024) · L Endocrinologo · doi:10.1007/s40619-024-01488-7 · Cited by 1
“Le PcDM1 sono continuamente a rischio di ipoglicemia, che è la principale barriera all’otte-nimento di un controllo glicemico ottimale [7].”
Elamin, A., & Teckchandani, S. (2024) · Springer eBooks · doi:10.1007/978-981-97-6406-8_24 · Cited by 1
Dehydration-induced AVP stimulates glucagon release and ketogenesis
Hill, T. G., Briant, L. J. B., Kim, A., Wu, Y., Rorsman, P., Asterholm, I. W., & Benrick, A. (2025) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00505.2024 · Cited by 5
Neuroendocrine mechanisms of behavioral changes induced by hypoglycemia
Park, M. J. (2010) · Illinois Digital Environment for Access to Learning and Scholarship (University of Illinois at Urbana-Champaign) · Cited by 1
Hypoglykämien bei Kindern und Jugendlichen mit Typ-1-Diabetes
Ziegler, R., & Kiess, W. (2013) · Der Diabetologe · doi:10.1007/s11428-012-0976-0 · Cited by 1
Screening for Chronic Complications in Type 1 Diabetes
Dorsey, R. R. (2006) · D-Scholarship@Pitt (University of Pittsburgh) · Cited by 1
Protein Kinases and Pancreatic Islet Function
Xavier, G. D. S. (2012) · InTech eBooks · doi:10.5772/37282 · Cited by 1
“The lack of a counter regulatory response leads to potential danger from episodes of hypoglycaemia and is a limiting factor for good glycaemic management in diabetes (43).”
BackgroundHypoglycemia, diabetes and atherosclerosis: is there a link?
Conget, I., & Giménez, M. (2011) · Diabetes Management · doi:10.2217/dmt.11.15 · Cited by 1
Role of physical exercise in persons presenting with diabetes mellitus
Hernández, J., Rodríguez, I., & Emiliano, M. (2010) · Revista cubana de endocrinología · Cited by 1
Metabolic control and depression in type 1 diabetes mellitus
Mokhort, T. V., & Navmenova, Y. (2015) · Diabetes Mellitus · doi:10.14341/dm2015247-53 · Cited by 1
Physical activity level and hypoglycemia in type 1 diabetes patients
Duarte, C. K., Rodrigues, T. D. C., Merker, A. J. S., Brauner, F. D. O., & de Almeida, J. C. (2016) · Clinical & Biomedical Research · doi:10.4322/2357-9730.62173 · Cited by 1
“1661 Diabetes duration (years) 19 (14-26) 16 (11-21) 18.”
Fujita, S., Kozawa, J., Ishibashi, C., Kimura, T., Kitamura, T., Fukui, K., Yasuda, T., Iwahashi, H., Imagawa, A., & Shimomura, I. (2017) · Internal Medicine · doi:10.2169/internalmedicine.56.8489 · Cited by 3
“An impaired awareness of hypoglycemia is a status characterized by a reduced ability to perceive the onset of hypoglycemia and it is associated with a sixfold increased risk of severe hypoglycemia (1), which is a life-threatening event requiring another person’s assistance to restore the blood glucose levels.”
BackgroundSevere hypoglycemia in diabetics requiring hospitalization and short-term mortality
Jain, A., Tak, S., & Lakhotia, M. (2017) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-017-0583-0 · Cited by 2
“Were it not for the barrier of hypoglycemia, people with diabetes could have normal HbA1c levels over a lifetime of diabetes [10].”
BackgroundInfluentialHerranz-Antolín, S., de Frutos, V. Á., & Torralba, M. (2018) · Endocrinología Diabetes y Nutrición (English ed ) · doi:10.1016/j.endien.2018.04.001 · Cited by 1
Lv, D., Garcia‐Tirado, J., & Fabris, C. (2018) · OBM Transplantation · doi:10.21926/obm.transplant.1803019 · Cited by 2
Development of an Insulin-Prescribing Chart for Paediatric Diabetes
Finn, B. P., O’Neill, T., Bradfield, A., O’Sullivan, T., Beattie, S., & O'Connell, S. M. (2019) · PubMed · Cited by 1
Ipsen, E. Ø., Hemmingsen, B., Petersen, L. Ø., Metzendorf, M., & Richter, B. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013824 · Cited by 2
Type 1 diabetes mellitus in children
Klinika za pedijatriju, K. R., Severinski, S., Ahel, I. B., Klinika za pedijatriju, K. R., Božinović, I., & Medicinski fakultet Sveučilišta u Rijeci, R. (2016) · Medicina · doi:10.21860/medflum2016_4ser · Cited by 1
Nasal glucagon: A new hope for severe hypoglycemia in type 1 diabetes
Heba, S. F., Parveen, U., Khanum, S. S. A., Gulnaaz, M., Tabassum, M., & Safiyya, S. B. (2021) · Journal of Diabetes and Endocrine Practice · doi:10.4103/jdep.jdep_6_20 · Cited by 1
Dumber, D. (2020) · Indian Journal of Forensic Medicine & Toxicology · doi:10.37506/ijfmt.v14i4.12266 · Cited by 1
Chandran, K., Tai, K. P., Toh, M. P. H. S., Phng, F. W. L., Seah, E.-J. D., & Wu, C. X. (2019) · Journal of Endocrinology and Metabolism · doi:10.14740/jem563 · Cited by 1
Hypoglycaemia in the over 75s: Understanding the predisposing factors in type 2 diabetes (T2DM)
Heald, A. H., Anderson, S. G., Cholakova, V., Narajos, M., Khan, A. R., Donnahey, G., & Livingston, M. A. (2017) · International Journal of Clinical Practice · doi:10.1111/ijcp.12932 · Cited by 1
Duman, T. T., Aktaş, G., Tel, B. M. A., Bilgin, S., Kahveci, G., & Kurtkulağı, Ö. (2022) · Journal of Public Health · doi:10.1007/s10389-022-01769-1 · Cited by 2
“…insulin treatment is often postponed by both patients and physicians for many reasons, such as the need for injection, risk of hypoglycemia, necessity of strict blood glucose monitoring, fear of weight gain, and the possibility of decreased treatment compliance (Cryer 2002; Lasserson et al. 2009).”
BackgroundEnergy Homeostasis and the Tumor/Host Interaction: The role of the Brain
Wiater, M. F. (2005) · Springer eBooks · doi:10.1007/1-4020-3414-8_14 · Cited by 1
Sherin, A., & Paulose, C. S. (2010) · Dyuthi Digital Repository (Cochin University of Science and Technology) · Cited by 1
Treatment of Type 2 Using Insulin: When to Introduce?
Rosenstock, J., & Owens, D. R. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-572-5_5 · Cited by 1
“Indeed, achieving and maintaining euglycemia has been an elusive goal because of the pharmacokinetic imperfections of old human insulins and the resulting barrier of hypoglycemia ( 45 ,46).”
BackgroundInsulin, glucagon, and hypoglycemic drugs
Krans, H. M. J. (2003) · Side effects of drugs annual · doi:10.1016/s0378-6080(03)80049-1 · Cited by 1
Schwerpunkt: Endokrine und metabolische Krisen
Reschke, K., Lehnert, H., & Magdeburg, O.-V.-G.-U. (2003) · Cited by 1
McCall, A. L. (2005) · Current Diabetes Reports · doi:10.1007/s11892-005-0088-y · Cited by 1
Ambler, G. R., Cameron, F. J., Joshi, K., & Wherrett, D. K. (2019) · Wiley eBooks · doi:10.1002/9781119152712.ch15 · Cited by 1
Cryer, P. E., & Frier, B. M. (2004) · International Textbook of Diabetes Mellitus · doi:10.1002/0470862092.d0707 · Cited by 1
Self-citationFrier, B. M. (2007) · Elsevier eBooks · doi:10.1016/b978-012373947-6.00209-9 · Cited by 2
Robinson, V. M. (2008) · ERA · Cited by 2
Bertazone, T. M. A., Rodrigues, F. F. L., Neiva, C. M., Teixeira, C. R. D. S., Bertazone, É. D. C., & Zanetti, M. L. (2015) · Reme Revista Mineira de Enfermagem · doi:10.5935/1415-2762.20150022 · Cited by 1
Puente, E. C. (2011) · Open Scholarship Institutional Repository (Washington University in St. Louis) · doi:10.7936/k7nk3c14
Robinson, R., & Paulose, C. S. (2007) · Dyuthi Digital Repository (Cochin University of Science and Technology)
Equipement op de huisartsenpost voor behandeling van diabetespatiënten
Holtrop, R. (2008) · Bohn Stafleu van Loghum eBooks · doi:10.1007/978-90-313-6312-4_3
Metadata
- Authors
- Cryer, P.
- Affiliations
- Washington University in St. Louis (US)
- Corresponding author
- Cryer, P.
- Venue
- Diabetologia
- Published
- 2002-06
- Volume
- 45
- Issue
- 7
- Pages
- 937-948
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2124282046
- Semantic Scholar
- ebdcc733bdd208ee1005932d38511abefb8034d6
- Cited by
- 794
- References
- 58
- Citations by year
- 2026: 4 · 2025: 10 · 2024: 11 · 2023: 15 · 2022: 16 · 2021: 22 · 2020: 18 · 2019: 24 · 2018: 39 · 2017: 49 · 2016: 32 · 2015: 60 · 2014: 65 · 2013: 66 · 2012: 53
- FWCI
- 12.98
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5p60dk020579-35)
- National Institute of Diabetes and Digestive and Kidney Diseases (R37DK027085, P60-DK20579, R37-DK27085, T32 DK07120, T32DK007120)
- National Center for Research Resources (M01-RR00036, M01RR000036)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Patient Safety and Medication Errors
- Keywords
- hypoglycemia, hypoglycemia unawareness, glucose counterregulation, insulin excess, epinephrine response, glucagon response, type 1 diabetes, type 2 diabetes, glycemic control
- MeSH terms
- Blood Glucose, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Epinephrine, Glucagon, Humans, Hypoglycemia, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.